iRhythm Holdings, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $747.1 | $591.8 | $492.7 | $410.9 | $322.8 |
| Operating income | -$57.4 | -$115.5 | -$125.2 | -$113.8 | -$99.9 |
| Net income | -$44.6 | -$113.3 | -$123.4 | -$116.2 | -$101.4 |
| Balance Sheet | |||||
| Total debt | — | — | — | — | $21.4 |
| Cash Flow Statement | |||||
| Free cash flow | $34.5 | -$30.6 | -$90.5 | -$52.8 | -$65.8 |
| Dividends | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| Share repurchases | $0.0 | $25.0 | $0.0 | $0.0 | — |
Shares outstanding 33.0M · Free float 97.7%
Annual filing data through FY ended December 31, 2025; float as of September 28, 2026.
Earnings
Other Coverage
October 8, 2026
Small-Cap Signal
Magnolia debt falls faster after WildFire close
October 5, 2026
Deals
iRhythm to Buy VitalConnect in $287.5 Million Mixed Deal
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
August 7, 2026
Deals
iRhythm to Buy Vital Connect in $287.5 Million Cardiac-Monitoring Deal